FOLD - Amicus Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

FOLD is currently covered by 10 analysts with an average price target of $19.21. This is a potential upside of $11.22 (140.43%) from yesterday's end of day stock price of $7.99.

Amicus Therapeutics's activity chart (see below) currently has 109 price targets and 95 ratings on display. The stock rating distribution of FOLD is 79.17% BUY and 20.83% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 46.74% with an average time for these price targets to be met of 354.71 days.

Highest price target for FOLD is $108, Lowest price target is $9, average price target is $25.5.

Most recent stock forecast was given by JEFFREY HUNG from MORGAN STANLEY on 17-Jul-2025.

Currently out of the existing stock ratings of FOLD, 19 are a BUY (79.17%), 5 are a HOLD (20.83%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$108

$100.01 (1251.69%)

$12

1 months 27 days ago
(17-Jul-2025)

0/5 (0%)

$101.71 (1617.01%)

Hold

$9

$1.01 (12.64%)

$14

4 months 11 days ago
(02-May-2025)

4/6 (66.67%)

$2.33 (34.93%)

165

Buy

$21

$13.01 (162.83%)

$21

7 months 29 days ago
(15-Jan-2025)

0/7 (0%)

$11.73 (126.54%)

Buy

$17

$9.01 (112.77%)

$16

10 months 1 days ago
(12-Nov-2024)

6/15 (40%)

$6.51 (62.06%)

454

Buy

$15

$7.01 (87.73%)

$13

10 months 6 days ago
(07-Nov-2024)

2/4 (50%)

$4.02 (36.61%)

434

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is FOLD (Amicus Therapeutics) average time for price targets to be met?

On average it took 354.71 days on average for the stock forecasts to be realized with a an average price target met ratio 46.74

Which analyst has the current highest performing score on FOLD (Amicus Therapeutics) with a proven track record?

DEBJIT CHATTOPADHYAY

Which analyst has the most public recommendations on FOLD (Amicus Therapeutics)?

Debjit Chattopadhyay works at GUGGENHEIM and has 7 price targets and 3 ratings on FOLD

Which analyst is the currently most bullish on FOLD (Amicus Therapeutics)?

Jeffrey Hung with highest potential upside - $100.01

Which analyst is the currently most reserved on FOLD (Amicus Therapeutics)?

Gil Blum with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?